Plasma Fibrinopeptide A and Beta-Thromboglobulin in Pre-Eclampsia and Pregnancy Hypertension

 

PDF Download Buy Article Permissions and Reprints

Summary

Increased plasma levels of β-thromboglobulin (βTG) and fibrinopeptide A (FPA), markers of platelet release and thrombin generation respectively, were measured in normal women, women taking oral contraceptives, normal pregnancy and pregnant women with hypertension or pre-eclampsia. No significant increases in βTG or FPA were found in women taking oral contraceptives. Significantly increased concentrations of βTG, but not FPA, were found in normal pregnant women in the second and third trimester of pregnancy when compared with nonpregnant age-matched controls. In eleven women with pregnancy hypertension and thirteen women with pre-eclampsia significantly elevated levels of both βTG and FPA were found when compared with age, parity and gestation-matched pregnant controls. Although the mean value for both βTG and FPA in the group with pre-eclampsia was higher than the group with pregnancy hypertension, the difference was not statistically significant. These findings provide additional evidence that pre-eclampsia and pregnancy hypertension are associated with activation of the coagulation system and the platelet release reaction.

• References

• 1 Bonnar J, McNicol G P, Douglas A S. Coagulation and fibrinolytic systems in pre-eclampsia and eclampsia. Br Med J 1971; 2: 12-16
  CrossrefPubMedGoogle Scholar
• 2 McKillop C, Howie PW, Forbes CD, Prentice CRM. Soluble fibrinogen/fibrin complexes in pre-eclampsia. Lancet 1976; 1: 56-58
  PubMedGoogle Scholar
• 3 Boneu R, Bierme R, Fournie A, Pontonnier G. Factor-VIII complex, fetal growth retardation and toxaemia. Lancet 1977; 1: 263
  PubMedGoogle Scholar
• 4 Thornton CA, Bonnar J. Factor VIII-related antigen and factor VIII coagulant activity in normal pregnancy, pre-eclampsia and abraptio placentae. In: Pregnancy Hypertension. Ed. Bonnar J, Magillivray I, Symonds M. 419-425 M.T.P. Press Ltd: Lancaster, England;
  Google Scholar
• 5 Zahavi J, Kakkar VV. β-thromboglobulin – a specific marker of in-vivo platelet release reaction. Thromb Haemostas 1980; 44: 23-29
  PubMedGoogle Scholar
• 6 Wilner GD. Molecular basis for measurement of circulating fibrinogen derivatives. In: Progress in Haemostasis and Thrombosis. 4: Ed. Spaet TH. Grune and Stratton; New York: 1980: 211-248
  Google Scholar
• 7 Arandi M, Saez M, Abril V, Carach J, Castells E, Castellanos JM. β-thromboglobulin levels and oral contraception. Lancet 1979; ii: 308-309
  PubMedGoogle Scholar
• 8 Duncan A. β-thromboglobulin levels and oral contraception. Lancet 1979; ii: 631
  PubMedGoogle Scholar
• 9 Redman CWG, Allington MJ, Bolton FG, Stirrat GM. Plasma-β-thromboglobulin in pre-eclampsia. Lancet 1977; ii: 248
  PubMedGoogle Scholar
• 10 Ludlam CA, Moore S, Bolton AE, Pepper OS, Cash JD. The release of human platelet specific protein measured by a radioimmunoassay. Thromb Res 1975; 6: 543-548
  CrossrefPubMedGoogle Scholar
• 11 Nossel HL, Yudelman I, Canfield RE, Butler Jnr. VP, Spondis K, Wilner GO, Quereshi GD. Measurement of fibrinopeptide A in human blood. J Clin Invest 1974; 54: 43-53
  CrossrefPubMedGoogle Scholar
• 12 Kockum C. Radioimmunoassay of fibrinopeptide A – clinical applications. Thromb Res 1976; 8: 225-236
  CrossrefPubMedGoogle Scholar
• 13 Rakoczi I, Tallian F, Bagdany S, Gati I. Platelet life-span in normal pregnancy and pre-eclampsia as determined by a non-radioisotope technique. Thromb Res 1979; 15: 553-556
  CrossrefPubMedGoogle Scholar
• 14 Kanaide H, Shainoff JR. Cross-linking of fibrinogen and fibrin by fibrinstabilising factor (Factor XIIIa). J Lab Clin Med 1975; 85: 574-597
  PubMedGoogle Scholar
• 15 Whigham KAE, Howie PW, Drummond AH, Prentice CRM. Abnormal platelet function in pre-eclampsia. Br J Obstet Gynaecol 1978; 85: 28-32
  CrossrefPubMedGoogle Scholar
• 16 Gavras H, Oliver N, Aitchison J, Begg C, Briggs JD, Brown JJ, Horton PW, Lee F, Lever AF, Prentice CRM, Robertson JIS. Abnormalities of coagulation and the development of malignant phase hypertension. Kidney International 1975; 8: 252-261
  PubMedGoogle Scholar